Diabetic retinopathy (DR)
- Optimize glucose, BP + kidney risk
- Anti-VEGF treats proliferative disease/DME
- Panretinal photocoagulation remains durable for PDR
- Vitrectomy for nonclearing hemorrhage/traction
- Screening interval follows retinopathy severity
- Rapid glucose improvement can transiently worsen disease
Use at a glance
- Optimize glucose, BP + kidney risk
Practical pearls
- Anti-VEGF treats proliferative disease/DME
- Panretinal photocoagulation remains durable for PDR
- Rapid glucose improvement can transiently worsen disease
Other practical pearls
- Vitrectomy for nonclearing hemorrhage/traction
Monitoring / follow-up
- Screening interval follows retinopathy severity
Self-check
- What systemic factors are optimized in retinopathy?
Glucose, BP + kidney risk. - What can rapid glucose improvement transiently do to retinopathy?
Worsen it.
Drugs used for this (3)
All clinical uses · Open Diabetic retinopathy (DR) in the interactive console ↗